Non-alcoholic fatty liver disease (NAFLD) is the first cause of chronic liver disease
worldwide; it ranges from simple steatosis to steatohepatitis (NASH) and, potentially …

In obesity, excessive abdominal fat, especially the accumulation of visceral adipose tissue
(VAT), increases the risk of metabolic disorders, such as type 2 diabetes mellitus (T2DM) …

Background The prognostic value of triglyceride-glucose (TyG) related indices in non-
alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver …

Vitamin D is a crucial nutrient with many pleiotropic effects on health and various chronic
diseases. The purpose of this review is to provide a detailed report on the …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease.
NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine …

This review was conducted to clarify both the complex interrelationship between adiposity
and vitamin D and the clinical implications of vitamin D status on metabolic abnormalities …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic disease
throughout the Western world and is recognized as the main cause of cryptogenic cirrhosis; …

Nowadays, the nonalcoholic fatty liver disease represents the main chronic liver disease in
the Western countries, and the correct medical therapy remains a big question for the …

Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease worldwide, but underlying mechanisms are not fully understood. In recent …

非酒精性脂肪性肝病(non-alcoholic fatty liver disease, NAFLD) 的全球患病率持续上升,
与其密切相关的糖尿病, 代谢综合征, 以及由此产生的医疗负担也在同步增加. NAFLD …